Struthers Richard Scott's Form 4 filing
Crinetics Pharmaceuticals, Inc. (CRNX) · filed Aug 11, 2026
- Accession no.
- 0001628280-26-055700
- Filed
- Aug 11, 2026, 4:11 PM ET
- Trade date
- Aug 7, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 4 derivative transactions. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Struthers Richard ScottCIK 0001746298 | Director, Officer (President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 7, 2026 | Common Stock | MOption exerciseAcquired | +3,969 | $25.19 | +$99,979.11 | 408,747 | Direct | |
| Aug 7, 2026 | Common Stock | MOption exerciseAcquired | +4,422 | $22.61 | +$99,981.42 | 413,169 | Direct | |
| Aug 7, 2026 | Common Stock | MOption exerciseAcquired | +6,542 | $15.29 | +$100,027.18 | 419,711 | Direct | |
| Aug 7, 2026 | Common Stock | MOption exerciseAcquired | +4,995 | $20.02 | +$99,999.9 | 424,706 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 7, 2026 | Common Stock | MOption exerciseDisposed | −3,969 | $0.00 | $0 | 172,281 | Direct | |
| Aug 7, 2026 | Common Stock | MOption exerciseDisposed | −4,422 | $0.00 | $0 | 195,578 | Direct | |
| Aug 7, 2026 | Common Stock | MOption exerciseDisposed | −6,542 | $0.00 | $0 | 259,058 | Direct | |
| Aug 7, 2026 | Common Stock | MOption exerciseDisposed | −4,995 | $0.00 | $0 | 244,205 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.